Valve in Valve (ViV) for bioprosthetic aortic

valve failure.

Transcatheter Aortic Valve Impantation

K. Toutouzas

Ass. Professor of Cardiology

Athens Medical School, Hippokration Hospital

MANAGEMENT OF PROSTHETIC VALVE DYSFUNCTION

23 mm EVOLUT-R Aortic ViV in regurgitant

Mosaic bioprosthesis

23 mm EVOLUT-R Aortic ViV in regurgitant

Mosaic bioprosthesis

23 mm EVOLUT-R Aortic ViV in regurgitant

Mosaic bioprosthesis

23 mm EVOLUT-R Aortic ViV in regurgitant

Mosaic bioprosthesis

Conclusions

• TAVI should be considered for VIV

• We need extensive preoperation assessment

• The surgical procedure and device plays important role

• Stenosis has worse outcome

• The hemodynamic results are inferior to TAVI in native valves